Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.

NCT02154776 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Breast Cancer

Interventions

DRUG: LEE011
DRUG: Buparlisib
DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals